Oral methyl-xanthines for bronchiectasis
Related Experiment Video
Updated: Sep 10, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
K Steele1, M Greenstone, J A Lasserson
1Thoracic Department, Royal Bournemouth Hospital, Castle Lane East, Bournemouth, UK, BH7 7DW.
Background:
Bronchiectasis is characterised by chronic sputum production,bronchial wall dilation,recurrent infection and airflow limitation. Methylxanthines are used in the management of airflow limitation associated with asthma and COPD, where they are also purported to have anti-inflammatory properties. In theory they may be of use in bronchiectasis.
Objectives:
To determine the efficacy of methylxanthines in the treatment of bronchiectasis.
Search Strategy:
The Cochrane Airways Group clinical trials register derived from MEDLINE,EMBASE and hand searches using the terms bronchiectasis, aminophylline, theophylline and methyl- xanthine
Selection Criteria:
Only randomised controlled trials were to be considered.
Data Collection And Analysis:
The results of the searches were reviewed by two authors. Searches yielded seven trials none of which met the inclusion criteria.
Main Results:
No randomised controlled trials were identified.
Reviewer'S Conclusions:
Further research is required to establish if the methylxanthines have a role in the treatment of bronchiectasis.
Related Concept Videos
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Antiasthma Drugs: Muscarinic Receptor Antagonists
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...

